Bumrungrad Hospital PCL (BKK:BH)
Thailand · Delayed Price · Currency is THB 167.50
-0.50 (-0.30%)
At close: Jan 30, 2026
Bumrungrad Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 25,151 | 25,718 | 25,376 | 20,721 | 12,460 | 12,362 |
Other Revenue | 258.95 | 144.87 | 170.76 | 186.97 | 144.1 | 77.83 |
| 25,410 | 25,862 | 25,547 | 20,908 | 12,605 | 12,440 | |
Revenue Growth (YoY) | -1.85% | 1.23% | 22.19% | 65.87% | 1.32% | -32.97% |
Cost of Revenue | 12,223 | 12,503 | 12,895 | 11,099 | 7,731 | 7,677 |
Gross Profit | 13,186 | 13,359 | 12,652 | 9,808 | 4,874 | 4,763 |
Selling, General & Admin | 4,243 | 4,171 | 4,180 | 3,798 | 3,296 | 3,394 |
Operating Expenses | 4,243 | 4,171 | 4,180 | 3,798 | 3,296 | 3,394 |
Operating Income | 8,943 | 9,188 | 8,472 | 6,010 | 1,578 | 1,368 |
Interest Expense | -7.19 | -8.33 | -2.39 | -3.55 | -119.76 | -127.62 |
Interest & Investment Income | 231.7 | 279.47 | 140.95 | 45.95 | 68.78 | 127.89 |
Earnings From Equity Investments | -0.71 | -0.43 | -0.9 | -0.51 | -68.87 | -2.38 |
Currency Exchange Gain (Loss) | 5 | -22.73 | 28.06 | -3.27 | -1.91 | 4.7 |
Pretax Income | 9,172 | 9,436 | 8,638 | 6,049 | 1,456 | 1,371 |
Income Tax Expense | 1,592 | 1,604 | 1,583 | 1,072 | 215.85 | 149.68 |
Earnings From Continuing Operations | 7,580 | 7,832 | 7,055 | 4,977 | 1,240 | 1,221 |
Minority Interest in Earnings | -50.34 | -57.33 | -48.68 | -38.54 | -24.35 | -17.12 |
Net Income | 7,529 | 7,775 | 7,006 | 4,938 | 1,216 | 1,204 |
Net Income to Common | 7,529 | 7,775 | 7,006 | 4,938 | 1,216 | 1,204 |
Net Income Growth | -0.83% | 10.96% | 41.88% | 306.21% | 0.96% | -67.87% |
Shares Outstanding (Basic) | 795 | 795 | 795 | 795 | 795 | 782 |
Shares Outstanding (Diluted) | 867 | 867 | 867 | 867 | 867 | 867 |
EPS (Basic) | 9.47 | 9.78 | 8.81 | 6.21 | 1.53 | 1.54 |
EPS (Diluted) | 8.68 | 8.96 | 8.08 | 5.69 | 1.40 | 1.39 |
EPS Growth | -0.92% | 10.89% | 42.00% | 306.43% | 0.72% | -67.82% |
Free Cash Flow | 7,105 | 7,455 | 5,522 | 5,067 | 2,753 | 1,372 |
Free Cash Flow Per Share | 8.19 | 8.59 | 6.37 | 5.84 | 3.17 | 1.58 |
Dividend Per Share | 5.000 | 5.000 | 4.500 | 3.500 | 3.200 | 3.200 |
Dividend Growth | -2.91% | 11.11% | 28.57% | 9.38% | - | - |
Gross Margin | 51.90% | 51.66% | 49.53% | 46.91% | 38.66% | 38.29% |
Operating Margin | 35.20% | 35.53% | 33.16% | 28.75% | 12.52% | 11.00% |
Profit Margin | 29.63% | 30.06% | 27.43% | 23.62% | 9.64% | 9.68% |
Free Cash Flow Margin | 27.96% | 28.82% | 21.62% | 24.23% | 21.84% | 11.03% |
EBITDA | 9,852 | 10,115 | 9,405 | 6,938 | 2,553 | 2,387 |
EBITDA Margin | 38.77% | 39.11% | 36.81% | 33.18% | 20.26% | 19.19% |
D&A For EBITDA | 908.77 | 927.23 | 933.08 | 927.49 | 975.86 | 1,018 |
EBIT | 8,943 | 9,188 | 8,472 | 6,010 | 1,578 | 1,368 |
EBIT Margin | 35.20% | 35.53% | 33.16% | 28.75% | 12.52% | 11.00% |
Effective Tax Rate | 17.36% | 17.00% | 18.32% | 17.72% | 14.83% | 10.92% |
Revenue as Reported | 25,410 | 25,862 | 25,575 | 20,908 | 12,605 | 12,445 |
Advertising Expenses | - | 537.6 | 494.86 | 414.75 | 233.74 | 234.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.